TTP has been reported to be downregulated in several tumors such as glioma,8 colon cancer,9 gastric cancer,10 and liver cancer,11 and emerging evidences show that TTP can act as a tumor suppressor via destabilizing mRNAs of downstream target oncogenes. This evidence concerns the gene ZFP36 and glioma.